A Study of BGM0504 in Early T2DM With Obesity

NCT07743983 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes (T2DM)

Interventions

DRUG: BGM0504
DRUG: semaglutide

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.